Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FJ5R7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,315
Award facts
- Contract value 100% obligated
- $22,314.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 5 mg with a ceiling value of $22,314.74 under a firm fixed-price contract structure. The award was issued on January 26, 2026, with an ultimate completion date of January 27, 2026, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with Cencora, Inc. functioning as the parent organization. This delivery order is executed under the larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026, which serves as a global pharmaceutical support vehicle for military healthcare programs.
Eliquis, an anticoagulant medication, represents one of many pharmaceutical products supplied through this expansive contract vehicle. AmerisourceBergen's substantial portfolio demonstrates its critical role in supporting federal medical supply chains, delivering prescription medications, vaccines, and medical supplies across multiple therapeutic domains to military treatment facilities, the Defense Health Agency, and other government healthcare systems. The firm fixed-price structure and rapid completion timeline reflect the nature of routine pharmaceutical procurement under the broader DLA medical supply framework, ensuring continuity of essential medications for federal beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FJ5R7?
SPE2DR26FJ5R7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FJ5R7 worth?
The government has obligated $22,315 on SPE2DR26FJ5R7.
Is contract SPE2DR26FJ5R7 an order under another contract?
Yes. SPE2DR26FJ5R7 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ5R7 competed?
The extent of competition for SPE2DR26FJ5R7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award